Monoclonal Mouse anti‑Human MED27 / CRSP8 Antibody (clone OTI2A4, Carrier‑free, aa24‑247, WB) LS‑C792021
Monoclonal Mouse anti‑Human MED27 / CRSP8 Antibody (clone OTI2A4, Carrier‑free, aa24‑247, WB) LS‑C792021
Antibody:
MED27 / CRSP8 Mouse anti-Human Monoclonal (aa24-247) (Carrier-free) (OTI2A4) Antibody
Format:
Unconjugated, Carrier-free
Overview
Antibody:
MED27 / CRSP8 Mouse anti-Human Monoclonal (aa24-247) (Carrier-free) (OTI2A4) Antibody
Format:
Unconjugated, Carrier-free
Specifications
Description
CRSP8 antibody LS-C792021 is an unconjugated mouse monoclonal antibody to human CRSP8 (MED27) (aa24-247). Validated for WB.
Target
Human MED27 / CRSP8
Synonyms
MED27 | CRAP34 | CRSP complex subunit 8 | Mediator complex subunit 27 | TRAP37 | p37 TRAP/SMCC/PC2 subunit | CRSP34 | CRSP8
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites.
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Human recombinant protein fragment corresponding to amino acids 24-247 of human MED27(NP_004260) produced in E.coli.
Applications
- Western blot (1:500 - 1:2000)
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Reactivity:
Human
Range:
0.156-10 ng/ml
Reactivity:
Human
Range:
0.78-50 ng/ml
Reactivity:
Human
Range:
0.156-10 ng/ml
Reactivity:
Human, Mouse, Rat
Range:
Species:
Human
Applications:
Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 4/27/2024